My brokers are saying we holders are on the cusp of a new beginning for the company. Placement going to high nets who are there for the ex Resmed team coming on board as well as sales and production roll out kicking off in the next quarter.
The research report I got in the mail has given me confidense that we are at a pivotal turning point and new VP Sales and Marketing Paul Eisen has some major roll out initiatives.
Looking forward to next week when we come back on....cashed up with a global production outlook!!!
DYOR.
KSX Price at posting:
5.0¢ Sentiment: Buy Disclosure: Held
